Searchable abstracts of presentations at key conferences in endocrinology
ISSN 1470-3947 (print)
| ISSN 1479-6848 (online)
Endocrine Abstracts
Menu
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Search
Issues/Conferences
Cite
About
Our Services
Policies
Contact
Disclaimer
Previous issue
|
Volume 35
|
ECE2014
|
Next issue
16th European Congress of Endocrinology
All volumes
0104 SFEIES24
0103 BSPED2024
0102 EYES2024
0101 ETA2024
0100 SFEEU2024
0099 ECE2024
0098 NANETS2023
0097 BES2023
0096 UKINETS2023
0095 BSPED2023
0094 SFEBES2023
0093 EYES2023
0092 ETA2023
0091 SFEEU2023
0090 ECE2023
0089 NANETS2022
0088 BES2022
0087 UKINETS2022
0086 SFEBES2022
0085 BSPED2022
0084 ETA2022
0083 EYES2022
0082 SFEEU2022
0081 ECE2022
0080 UKINETS2021
0079 BES2021
0078 BSPED2021
0077 SFEBES2021
0076 CHD2021
0075 EYES2021
0074 SFENCC2021
0073 ECE2021
0072 UKINETS2020
0071 BES2020
0070 ECE2020
0069 SFENCC2020
0068 UKINETS2019
0067 EYES2019
0066 BSPED2019
0065 SFEBES2019
0064 BES2019
0063 ECE2019
0062 EU2019
0061 OU2019
0060 UKINETS2018
0059 SFEBES2018
0058 BSPED2018
0057 BES2018
0056 ECE2018
0055 SFEEU2018
0054 NuclearReceptors2018
0053 OU2018
0052 UKINETS2017
0051 BSPED2017
0050 SFEBES2017
0049 ECE2017
0048 SFEEU2017
0047 Theranostics2016
0046 UKINETS2016
0045 BSPED2016
0044 SFEBES2016
0043 WCTD2016
0042 Androgens2016
0041 ECE2016
0040 ESEBEC2016
0039 BSPED2015
0038 SFEBES2015
0037 ECE2015
0036 BSPED2014
0035 ECE2014
0034 SFEBES2014
0033 BSPED2013
0032 ECE2013
0031 SFEBES2013
0030 BSPED2012
0029 ICEECE2012
0028 SFEBES2012
0027 BSPED2011
0026 ECE2011
0025 SFEBES2011
0024 BSPED2010
0023 BSPED2009
0022 ECE2010
0021 SFEBES2009
0020 ECE2009
0019 SFEBES2009
0018 MES2008
0017 BSPED2008
0016 ECE2008
0015 SFEBES2008
0014 ECE2007
0013 SFEBES2007
0012 SFE2006
0011 ECE2006
0010 SFE2005
0009 BES2005
0008 SFE2004
0007 BES2004
0006 SFE2003
0005 BES2003
0004 SFE2002
0003 BES2002
0002 SFE2001
Summary
Abstract Book
Programme
Volume Editors
eposters
Abstracts
Contents
Prize Lectures and Biographical Notes
The European Journal of Endocrinology Prize Lecture
Adrenocortical carcinoma - current concepts and future perspectives
ea0035eje1
European Journal of Endocrinology Prize Winner
ea0035eje1biog
The Geoffrey Harris Prize Lecture
Did the hand, then, of the potter shake?
ea0035gh1
Geoffrey Harris Prize Winner
ea0035gh1biog
Plenary Lectures
Genes, environment and endocrine disease
Genetics, environment and endocrine diseases
ea0035pl1
Advances in molecular pathogenesis of thyroid cancer therapeutic implications
Advances in molecular pathogenesis thyroid cancer: therapeutic implications
ea0035pl2
Good times, bad times: (patho)physiology of diurnal rhythms
Good times, bad times: (patho)physiology of diurnal rhythms
ea0035pl3
Islet transplantation
Islet Transplantation Plenary 5 (Tuesday 6th May 2014)
ea0035pl4
Simultaneous treatment of menopausal symptoms and prevention of breast cancer: Is it possible?
Menopausal hormone therapy and breast cancer: evidence of promotion not causation from tumor kinetic models
ea0035pl5
Hypothalamic inflammation cause or consequence of obesity?
Hypothalamic inflammation: cause or consequence of obesity?
ea0035pl6
Reproduction and energy metabolism, an ancestral balance to be preserved for women's health
Abstract unavailable
ea0035pl7
Symposia
Endocrine changes and treatment needs in critically ill patients
Thyroid dysfunction in critically ill patients: to treat or not to treat?
ea0035s1.1
Adrenal (dys)function in critically ill patients
ea0035s1.2
Abstract unavailable
ea0035s1.3
Pituitary development from basic research to clinical practice
Abstract unavailable
ea0035s2.1
Abstract unavailable
ea0035s2.2
Management of adult patients with disorders of pituitary development
ea0035s2.3
News from thyroid hormones: central transport, energy control and oxidative stress
Neuro-glial functional coupling in deiodination mediated thyroid hormone signaling
ea0035s3.1
Novel aspects of thyroid hormone transport in the mouse brain
ea0035s3.2
Oxidative damage to macromolecules in the thyroid gland: experimental evidence
ea0035s3.3
Endocrine Nurses Session 1: Craniopharyngioma
Craniopharyngioma: challenges in the management of patients with craniopharyngioma
ea0035s4.1
The role of the endocrine nurse in the long term care and treatment of patients post craniopharyngioma
ea0035s4.2
Psychological aspects of living with a pituitary related condition
ea0035s4.3
Obesity Beyond BMI
Abstract unavailable
ea0035s5.1
Relevance of body composition analysis
ea0035s5.2
Are metabolically obese individuals are really healthy?
ea0035s5.3
Focus on novel developments of PCOS conclusions from the PCOS Task Force
Abstract unavailable
ea0035s6.1
Diagnosis of PCOS
ea0035s6.2
Focus on novel developments of PCOS: conclusions from the PCOS Task Force: treatment of PCOS
ea0035s6.3
Nontumorous pituitary diseases
Abstract unavailable
ea0035s7.1
Unusual pituitary infections
ea0035s7.2
Abstract unavailable
ea0035s7.3
Membrane lipid composition and receptor function. Signalling and trafficking
Membrane lipid composition and receptor function
ea0035s8.1
Spatiotemporal control of endocytosis
ea0035s8.2
Membrane dynamics in physiology and disease: PI3K signaling
ea0035s8.3
EYES Session - Cold metabolic inflammation in obesity: ignored complication and treatment target?
Introducing EYES: European Young Endocrine Scientists
ea0035s9.1
Fertility: PCOS: metformin
ea0035s9.2
The emerging landscape for nanomedicine in atherosclerosis
ea0035s9.3
Difficulties in the treatment of Graves orbitopathy
New therapeutic approach in Graves' orbitopathy
ea0035s10.1
Radiotherapy in Graves' orbitopathy: current status
ea0035s10.2
When should we perform orbital decompression
ea0035s10.3
Long term outcome of cured pituitary patients
Long-term outcome of 'cured' patients: acromegaly
ea0035s11.1
Quality of life in patients with non-functioning pituitary adenomas
ea0035s11.2
Abstract unavailable
ea0035s11.3
Gut microbiota in diabetes and obesity
Abstract unavailable
ea0035s12.1
Fecal transplantation in obesity/type 2 diabetes Dr M Nieuwdorp
ea0035s12.2
Functional interactions between diet, microbiota and host: effects on intestinal architecture and host nutrient absorption
ea0035s12.3
Endocrine Nurse Session 3: Meet the Nurse Expert - Management of Endocrine Emergencies
Abstract unavailable
ea0035s13.1
Abstract unavailable
ea0035s13.2
Abstract unavailable
ea0035s13.3
Clinical outcome of medical intervention in Disorder of Sex Development (DSD)
dsd-LIFE: clinical European outcome study of disorders of sex development
ea0035s14.1
Consequences of the preservation of underdeveloped testes in adulthood
ea0035s14.2
Developmental disruption of paracrine hormone regulation in the pathogenesis of germ cell neoplasms
ea0035s14.3
Thromboembolism and contraception
Epidemiology of sex steroid-related thromboembolism
ea0035s15.1
Abstract unavailable
ea0035s15.2
The view of the gynecologist on thromboemboembolism
ea0035s15.3
Metformin: old dog, new tricks
Abstract unavailable
ea0035s16.1
Mechanisms of antitumoral activity of metformin in thyroid cancer
ea0035s16.2
Antitumoral effects of metformin on cancer stem cells: identification of novel molecular targets
ea0035s16.3
Cushings syndrome
Mortality: still increased despite cure in Cushing's disease?
ea0035s17.1
Abstract unavailable
ea0035s17.2
Medical therapy for endogenous hypercortisolism
ea0035s17.3
Endocrine disease during pregnancy
Pituitary tumours during pregnancy
ea0035s18.1
Pheochromocytoma/paraganglioma in pregnancy
ea0035s18.2
Congenital adrenal hyperplasia in pregnancy
ea0035s18.3
Osteoporosis - An update
Paediatric osteoporosis
ea0035s19.1
Denosumab: current perspectives
ea0035s19.2
Abstract unavailable
ea0035s19.3
New hormones and endocrine tissues
FGF21, irisin and other novel players in endocrine metabolic regulation
ea0035s20.1
Products of the ghrelin gene, their role in regulating [beta] cell and adipocyte function
ea0035s20.2
The gut: a key organ coordinating the brain control of energy homeostasis
ea0035s20.3
Dilemmas in hormonal replacements
Abstract unavailable
ea0035s21.1
Abstract unavailable
ea0035s21.2
Dilemmas in hormonal replacements: can we offer GH replacement to patients with a history of malignancy?
ea0035s21.3
Novel therapies for thyroid cancer
Abstract unavailable
ea0035s22.1
Limits of targeted therapies and future developments
ea0035s22.2
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer
ea0035s22.3
Neuroendocrine tumours
Molecular pathogenesis of neuroendocrine tumours
ea0035s23.1
Abstract unavailable
ea0035s23.2
Abstract unavailable
ea0035s23.3
Nutrient regulation of metabolism and endocrine systems
Nutrient regulation of metabolism and endocrine systems: using low-carbohydrate/high-fat diets to dissect macronutrient effects on endocrine systems
ea0035s24.1
Metabolic consequences of a high-fat diet on mouse models of GH action
ea0035s24.2
Abstract unavailable
ea0035s24.3
Gonadal hormones and obesity
Gonadal hormones and obesity: estrogens and body weight
ea0035s25.1
PCOS and obesity: unveiling the basic links
ea0035s25.2
Perinatal androgen exposure and body weight fate
ea0035s25.3
Pitfalls in hormone measurement
Guidelines on GH/IGF1 measurement
ea0035s26.1
Pitfalls in the measurement and interpretation of thyroid function tests
ea0035s26.2
Advantages in the measurement of steroid hormones
ea0035s26.3
Brown Adipose Tissue
White, brown, and pink adipocytes: the extraordinary plasticity of the adipose organ
ea0035s27.1
Abstract unavailable
ea0035s27.2
Brown adipose tissue: the wholy grail of metabolic disease
ea0035s27.3
Molecular pathophysiology for clinicians: receptor-related disorders
Abstract unavailable
ea0035s28.1
Disorders related to nuclear receptors
ea0035s28.2
Disorders related to calcium-sensing receptor signalling
ea0035s28.3
(1)
Mediterranean diet in the prevention of cardiovascular disease
ea0035s29.1
Meet the Expert Sessions
(1)
Abstract unavailable
ea0035mte1
Abstract unavailable
ea0035mte2
Premature ovarian insufficiency
ea0035mte3
The zebrafish, a teleost model recapitulating the mammalian molecular events during endocrine development and function
ea0035mte4
The Year in the Adrenals
ea0035mte5
Abstract unavailable
ea0035mte6
Therapeutic dilemmas in NETs
ea0035mte7
Abstract unavailable
ea0035mte8
Abstract unavailable
ea0035mte9
Pituitary disorders and osteoporosis
ea0035mte10
Abstract unavailable
ea0035mte11
Abstract unavailable
ea0035mte12
Pituitary apoplexy: diagnosis and management
ea0035mte13
Real-time monitoring of GPCR signalling in living cells
ea0035mte14
Abstract unavailable
ea0035mte15
Postmenopausal hyperandrogenism
ea0035mte16
FGF23 and phosphorus homeostasis: physiology and pathophysiology
ea0035mte17
Oral Communications
Thyroid clinical
Esophagus motility in overt hypothyroidism
ea0035oc1.1
Levothyroxine substitution in subclinical hypothyroidism: Does it have a beneficial effect on all-cause mortality?
ea0035oc1.2
Chronic liothyronine (T3) treatment in stable heart failure patients with low T3 syndrome: A randomised, double-blind, cross-over, placebo-controlled intervention study (The LIHFA study)
ea0035oc1.3
Consequences of experimental hyperthyroidism on brain structure and function in humans
ea0035oc1.4
rh-TSH (Thyrogen) aided radioiodine therapy in children and adolescents with DTC
ea0035oc1.5
Adrenal clinical
Armadillo repeat containing 5 gene (ARMC5) alterations in a large cohort of 98 ACTH-independant macronodular adrenal hyperplasia (AIMAH) patients: genotype/phenotype correlations.
ea0035oc2.1
Constitutive activation of PRKACA in adrenal Cushing's syndrome
ea0035oc2.2
Prognostic value of DNA methylation in adrenocortical carcinomas: an ENSAT study
ea0035oc2.3
Detection of pheochromocytoma by enzyme immunoassay measurements of plasma metanephrines requires appropriately established upper cut-offs of reference intervals
ea0035oc2.4
Treatment strategy and outcome with primary aldosteronism: a nationwide longitudinal cohort based study
ea0035oc2.5
Neuroendocrinology & Signalling
Constant intravenous infusion of kisspeptin-54 restores LH pulsatility in women with hypothalamic amenorrhoea
ea0035oc3.1
Copeptin in the diagnosis and differential diagnosis of diabetes dnsipidus - the 'CoSIP-study'
ea0035oc3.2
Evidence for interaction between the [beta]
2
-adrenergic and the insulin receptor
ea0035oc3.3
Role Of thyroid hormone receptor [beta] expression in lymphangiogenesis in breast carcinoma
ea0035oc3.4
NTRK3 receptor expression is strictly associated with medullary thyroid cancer RET mutation status
ea0035oc3.5
Diabetes and Obesity 1
The lower postprandial glucose oxidation in nondiabetic carriers of risk variants of TCF7L2 gene
ea0035oc4.1
Vildagliptin alone, and in half-dose combination with metformin, attenuates streptozotocin-induced diabetic nephropathy in high-fat fed heminephrectomized rats
ea0035oc4.2
Importance of neuropeptide Y as a predictor of nephropathy in type 2 diabetic patients
ea0035oc4.3
Endothelial progenitor Cells exhibit decreased function but increased numbers in overt type 2 diabetic nephropathy
ea0035oc4.4
A comparison of lipoprotein associated phospholipase A2 and high sensitive C-reactive protein levels between diabetic and non-diabetic patients with coronary artery disease
ea0035oc4.5
Adrenal & Thyroid
Diagnostic and therapeutic outcome in ERCUSYN: Preliminary report in over 1000 patients
ea0035oc5.1
Relationship between final height and cardiometabolic risk and quality of life in adults with congenital adrenal hyperplasia: United Kingdom Congenital adrenal Hyperplasia Adult Study Executive (CaHASE)
ea0035oc5.2
Mitotane induces endoplasmic reticulum stress triggering apoptosis and decrease of steroid hormone synthesis
ea0035oc5.3
MUC-1 - a novel preclinical model for adrenocortical carcinoma
ea0035oc5.4
Validation of follicular thyroid cancer molecular classifier in fine-needle aspiration biopsy samples
ea0035oc5.5
Bone, calcium & vitamin D
Ucma as a direct common target of Runx2 and Osterix promotes osteoblast differentiation
ea0035oc6.1
High spontaneous osteoclastogenesis in pediatric osteogenesis imperfecta patients receiving or not intravenous neridronate
ea0035oc6.2
Hypoparathyroidism: The burden of illness and impact on patients' personal lives
ea0035oc6.3
The REPEAT Study: An open-label clinical trial evaluating the safety and efficacy of recombinant human parathyroid hormone, rhPTH(1-84), for the treatment of hypoparathyroidism in hungary
ea0035oc6.4
The effect of recombinant human parathyroid hormone, rhPTH(1-84), on vitamin D metabolism and phosphate homeostasis: Results from phase III 24-Week REPLACE and phase I clinical studies
ea0035oc6.5
IGF-1 and Thyroid Basic
GH induces chemoresistance in human endometrial cancer cell lines involving ERK 1/2 and PKCdelta
ea0035oc7.1
The proposed molecular mechanism underlying isolated growth hormone deficiency (IGHD) caused by C53S mutation
ea0035oc7.2
Targeting the insulin-like growth factor 1 (IGF1R) and insulin (IR) receptor with a dual IGF1R/IR inhibitor, OSI-906, to potentiate mTOR inhibitor effects in experimental models of hepatocellular carcinoma (HCC)
ea0035oc7.3
Training MCT10 to transport thyroxine: Structure based targeted mutations in MCT10
ea0035oc7.4
Direct triiodothyronine effects in brown adipocytes
ea0035oc7.5
Pituitary clinical
Metabolic improvement after treatment of acromeglay is determined by the increase of gynoid fat mass and the decrease of serum vaspin and IGF1
ea0035oc8.1
Soluble [alpha]-Klotho - a new serum biomarker for the activity of acromegaly
ea0035oc8.2
Assessment of atrial electromechanical delay in patients with acromegaly
ea0035oc8.3
Normalization of urinary cortisol with the potent 11[beta]-hydroxylase inhibitor LCI699 in patients with Cushing's disease: 22-week, multicentre, open-label study
ea0035oc8.4
The effects of glucocorticoid treatment on cognition in patients with secondary adrenal insufficiency - results from a RCT
ea0035oc8.5
Reproduction
High frequency of FGFR1 mutations in patients with congenital hypogonadotropic hypogonadism and split hand/foot malformation
ea0035oc9.1
Tadalafil ameliorates metabolic syndrome-induced alterations in visceral adipose tissue and liver: an experimental study in the rabbit
ea0035oc9.2
Late onset hypogonadism influences the endothelial function in men with coronary artery disease
ea0035oc9.3
Kisspeptin - a novel physiological trigger for oocyte maturation in IVF treatment
ea0035oc9.4
IGF1 gene polymorphism in Polycystic Ovary Syndrome
ea0035oc9.5
Endocrine Tumours
Blood-borne and tissue microRNAs in adrenocortical tumours: affected pathways and diagnostic relevance
ea0035oc10.1
The cytotoxic effect of sunitinib on human bronchial carcinoid cell lines and primary cultures is counteracted by EGF and IGF-1 but not by VEGF
ea0035oc10.2
The NMU signaling controls cancer progression of human RL95-2 endometrial cancer cells through cell motility maintenance
ea0035oc10.3
Mast cell interactions at tumour interface drive progression in human prostate cancer
ea0035oc10.4
Molecular mechanisms underlying the unexpected promoting effects of mifepristone on murine testicular Leydig cell tumorigenesis
ea0035oc10.5
Diabetes and Obesity 2
Inhibition of cardiac dysfunction in diabetic mice by treatment with brain natriuretic peptide
ea0035oc11.1
An audit of the management of inpatient glycaemia using point of care testing data at Manchester Royal Infirmary
ea0035oc11.2
Improvement or stabilization of retinopathy and visual acuity after islet transplantation: a 5-year prospective study
ea0035oc11.3
A novel adult human adipose stem cell model from inducible brown fat surrounding pheochromocytoma tumors
ea0035oc11.4
Lipodystophic laminopathies are characterised by an increased intra/whole abdominal fat ratio with preserved fat/lean mass ratio and hypoleptinemia, in contrast with obese people, compared to controls
ea0035oc11.5
Pituitary Basic
Human AIP gene rescue lethality in a Drosophila melanogaster knockout model of AIP orthologue
ea0035oc12.1
Differential in vitro response to octreotide and pasireotide in normal and tumoral primary pituitary cell cultures
ea0035oc12.2
Detection of pituitary antibodies by immunofluorescence: Methodological approach and results in patients with pituitary diseases
ea0035oc12.3
Identification and characterization of pituitary adenoma stem-like cells in human non functioning pituitary adenomas
ea0035oc12.4
Does hypercortisolism of Cushing's syndrome affect telomere length?
ea0035oc12.5
Nurse Posters
(1)
Level of knowledge about type I diabetes mellitus among nurses employed at endocrinological dispensaries
ea0035n1
Radiation-induced multiple late complications after childhood acute lymphoblastic leukemia: A case report
ea0035n2
Reduced psychological mental stress improved glycemic control in type 2 diabetic patients.
ea0035n3
Adherence to treatment for chronic hypogonadism: the role of illness perceptions and depressive symptoms
ea0035n4
Acromegaly patients' experiences of nursing
ea0035n5
Effects of PRKAR1A mutations in behavior and brain function
ea0035n6
The Nordic network for endocrine nurses (NNEN).
ea0035n7
Application of international classification of functioning, disability and health to assess physical function in patients with diabetes Mellitus
ea0035n8
Poster Presentations
Adrenal cortex
Which serum cortisol after high dose short synacthen test, 30 or 60 min?
ea0035p1
Development of new improved derivatives of iodometomidate for the diagnosis of adrenocortical tumours and radiotherapy of adrenal carcinoma
ea0035p2
Cardiovascular risk in Cushing's syndrome vs obesity
ea0035p3
ACTH-secreting pheochromocytoma: case report
ea0035p4
Are small adrenal incidentalomas solely a radiological finding?
ea0035p5
An autopsy case of ectopic ACTH-secreting lung carcinoid with Cushing's syndrome
ea0035p6
Favorable long-term outcome of bilateral adrenalectomy in Cushing's disease
ea0035p7
Analysis of BclI, N363S and ER22/23EK polymorphism of the glucocorticoid receptor gene in a large series of patients with adrenal incidentaloma
ea0035p8
Hormonal and clinical correlations in nonfunctional adrenal incidentalomas
ea0035p9
Clinical, laboratory findings and results of therapy in patients with Cushing's syndrome
ea0035p10
VEGF autocrine secretion is enhanced by EGFR activation trough ERK1/2 phosphorylation in human adrenocortical carcinoma cell lines
ea0035p11
New drugs switching off Wnt/[beta]-catenin signaling in adrenocortical tumor cells
ea0035p12
Effects of everolimus, nilotinib, imatinib and ZOL in combination with mitotane in monolayer and spheroids human adrenocortical tumor cell line
ea0035p13
Two uncommon adrenal incidentalomas
ea0035p14
Cushing's syndrome in women with polycystic ovary syndrome
ea0035p15
Adrenal hormons substitution in MElas syndrome
ea0035p16
Female to male gender identity disorder in a patient with non-classical congenital adrenal hyperplasia
ea0035p17
Adrenal function in glucocorticoid-treated patients with acute exacerbations of COPD: the 'REDUCE*' randomized trial
ea0035p18
Acute pasireotide suppression test in patients with Cushing's disease: a role in predicting long-term efficacy?
ea0035p19
Measurement of serum total cortisol using HPLC coupled ESI-TOF mass spectrometry
ea0035p20
Hypoaldosteronism post Conn's adenoma retroperitoneal adrenalectomy presenting with acute renal failure and hyperkalaemia requiring mineralocorticoid replacement
ea0035p21
Hyponatremia as a predictor of in-hospital mortality
ea0035p22
A case of an accessory spleen mimicking a nonfunctional incidentaloma
ea0035p23
Bone mineral density, markers of bone remodeling, and quality of life in patients with Cushing's syndrome after 12 months of remission
ea0035p24
Subclinical hypercortisolemia: who should be operated?
ea0035p25
Recovery of the hypothalamo-pituitary adrenal axis following successful surgical treatment in various forms of Cushing's syndrome
ea0035p26
A three generation family with low cortisol, CBG deficiency, chronic fatigue and pain, lipomatosis and behavioral alterations
ea0035p27
Adrenal incidentaloma: current situation in Lithuania
ea0035p28
The treatment with glucocorticoids in congenital adrenal hyperplasia: short- and long-term effects of the switch from conventional glucocorticoids to 'dual release' hydrocortisone on metabolic and hormonal profile
ea0035p29
Development of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency
ea0035p30
Postpartum adrenocortical deficiency: a case report
ea0035p31
Relative adrenal insufficiency in acute ischaemic stroke
ea0035p32
Circadian cortisol and GH profiles in patients with Addison's disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy
ea0035p33
High risk for adrenal crises in patients with autoimmune Addison's disease: health insurance data 2008-2012
ea0035p34
Glucocorticoid-induced adrenal insufficiency in prednisolone treated patients and how it relates to glucocorticoid dose and the duration of treatment
ea0035p35
An endocrine dilemma: adrenal tumor
ea0035p36
Cardiovascular outcome in patients with primary aldosteronism following adrenalectomy and mineralocorticoid antagonist treatment: prospective results of the Munich Conn Center
ea0035p37
Mitochondrial thiol systems are important players in antioxidant defence for the human adrenal cortex
ea0035p38
Behavioural research into adrenal insufficiency (AI) patients' perceptions of AI medication, symptoms and adherence: results of a multi-country, European online survey
ea0035p39
21-hydroxylase autoantibody positivity is influenced by HLA genotype in South African patients with Addison's disease
ea0035p40
Periodic cushing's disease: difficult patient, difficult management
ea0035p41
Could DHEA-S be a novel marker at distinguishing adrenal and pituitary Cushing?
ea0035p42
Detection of high rate of intercurrent illnesses and adrenal crisis in patients with adrenal insufficiency by using a patient's diary
ea0035p43
Bone mineral density does not decrease in patients with adrenal insufficiency on a low daily glucocorticoid dose over a 2 year period
ea0035p44
Markedly elevated glucocorticoids and their metabolites in an unusual case of Cushing's syndrome secondary to ectopic ACTH production from a thymic carcinoid
ea0035p45
Diagnostic performance of late-night salivary cortisol measured by automated chemiluminescenze immunoassay
ea0035p46
Might cortisol modulate food choices in subclinical autonomous glucocorticoids hypersecretion?
ea0035p47
Retrospective analysis of adrenal incidentalomas: a single center experience
ea0035p48
The influence of diagnostic criteria on the interpretation of adrenal venous sampling
ea0035p49
The pathophysiology of aldosterone-producing adenomas associated with their tumor size: the smaller, the higher expression of CYP11B2
ea0035p50
The adrenal venous sampling is a difficult test in the localization of the primary hyperaldosteronism
ea0035p51
Late-night salivary cortisol as an initial test for Cushing's syndrome in the group of patients with obesity and type 2 diabetes mellitus
ea0035p52
Clinical characteristics and follow-up of patients with adrenal incidentalomas
ea0035p53
Effects of non-physiological concentrations of glucocorticoids on apoptotic cell death of human early hematopoietic stem/progenitor cells: in vitro studies
ea0035p54
Effects of adrenal insufficiency on body composition and metabolic indices: data from the European Adrenal Insufficiency Registry (EU-AIR)
ea0035p55
Takotsubo cardiomyopapthy and panhypopituitarism: case report
ea0035p56
Adrenal Medulla
ACTH-producing pheochromocytoma presenting with Cushing's syndrome and complicated by invasive aspergillosis: a case report
ea0035p57
Pheochromocytomas and paragangliomas: association between tumor size and measurements of metanephrines and catecholamines
ea0035p58
The value of metanephrines and normetanephrines influences blood pressure in patients with pheochromocytoma?
ea0035p59
Olygosimptomatic malignant pheochromocytoma treated with 131I-MIBG
ea0035p60
A difficult case of ectopic Cushing's syndrome due to ACTH-producing pheochromocytoma presented with normal fractionated urinary catecholamines and metanephrines
ea0035p61
Expression of IGF/mTOR pathway components in human pheochromocytomas and in vitro inhibition of PC12 rat pheochromocytoma cell growth by mTOR inhibitors alone and in combination with the dual IGFI-R/INS-R antagonist OSI-906
ea0035p62
Asymptomatic catecholamine-producing tumours in Von Hipple-Lindau disease
ea0035p63
Analysis of pheochromocytomas/paragangliomas from Eastern Slovakia
ea0035p64
Bone and Osteoporosis
Postpartum osteoporosis with acute evolution: case report
ea0035p65
The investigation of the awareness of bone health in patients with postmenopauosal in the region of Northeastern Anatolia
ea0035p66
Baseline characteristics of Greek patients enrolled in the ExFOS study
ea0035p67
From EFOS to ExFOS: any news with teriparatide prescription habits in Greece?
ea0035p68
Subclinical celiac disease presented with postpartum low-back pain: case report
ea0035p69
Vitamin D receptor (VDR) gene polymorphisms and the risk of low bone mass in type 1 diabetic patients
ea0035p70
Bone mineral density in Iranian patients: effects of age, sex, and BMI
ea0035p71
Characteristics of the endocrine osteoporosis
ea0035p72
Efficacy of zoledronic acid treatment in Paget disease of bone
ea0035p73
The relationship between the existence and degree of coronary atherosclerosis with the level of parathormone
ea0035p74
What factors influenced on femoral neck bone mineral density in postmenopausal women?
ea0035p75
Serum concentration of pentosidine and adipocytokines is related to fragile bone fractures in patients with type 2 diabetes mellitus
ea0035p76
A girl with a hard painful swelling at the right hip: hyperphosphatemic tumeral calcinosis
ea0035p77
Does testosteron have an effect on bone mineral density in postmenopausal women?
ea0035p78
Renal aspects of primary hyperparathyroidism
ea0035p79
1,25-dihydroxyvitamin D3 decreases the proinflammatory interleukin 17 serum levels
ea0035p80
Factors associated with vertebral fractures in patients with primary hyperparathyroidism
ea0035p81
Structure of bone disease the different clinical forms of primary hyperparathyroidism
ea0035p82
Low-carbohydrate/high-fat diets do not have negative effects on bone density in female rats in contrast to male rats
ea0035p83
Teriparatide treatment in a patient with severe pregnancy related osteoporosis
ea0035p84
The total fat mass and the fracture risk assessment: a study in 146 Romanian menopausal women
ea0035p85
The 10-year absolute fracture risk and central DXA correlations in 505 Romanian menopausal women
ea0035p86
Bone mineral density, bone turnover and vitamin D status in women with diabetes mellitus type 2 and healthy women with osteoporosis in menopause
ea0035p87
The -857C/T single-nucleotide polymorphism of TNF[alpha] gene is associated with bone mineral density in Greek peri- and postmenopausal women
ea0035p88
State of bone metabolism in patients with urolithiasis
ea0035p89
Familial hypocalciuric hypercalcemia: an important differential diagnosis from hyperparathyroidism
ea0035p90
Usefulness of serum sclerostin as a diagnostic marker of osteoporosis in a cohort of spanish postmenopausal women
ea0035p91
Increased osteoporotic fractures' risk in elderly patients with lower sodium levels
ea0035p92
The effects of recombinant human TSH on selected bone markers in the follow-up of patients treated for differentiated thyroid carcinoma
ea0035p93
Influence of osteoporosis risk factors on extensive suppression of bone metabolism during antiresorptive therapy
ea0035p94
Osteoporosis in young male secondary to cancer treatment: case report
ea0035p95
Jaw osteonecrosis in a patient with postmenopausal osteoporosis on antiresorptive treatment
ea0035p96
Assessment of OPG/RANK/RANKL gene expression levels in peripheral blood mononuclear cells after treatment with hormonal replacement therapy and tibolone in patients after menopause with osteopenia or postmenopausal osteoporosis
ea0035p97
Assessment of OPG and RANKL serum levels after treatment with hormonal replacement therapy and tibolone in patients after menopause with osteopenia or postmenopausal osteoporosis
ea0035p98
Effect of estroprogestagen treatment on bone mineral density and concentration of osteoprotegerin in girls with Turner syndrome
ea0035p99
Bone mineral density in girls with functional hypothalamic amenorrhea subjected to estroprogestagen treatment: a 4-year prospective study
ea0035p100
Calcium and Vitamin D metabolism
Predictive value of early phosphate measurement in post-thyroidectomy hypocalcemia: a prospective study
ea0035p101
The effect of FGF23 on renal phosphorus handling is dependent on PTH secretion
ea0035p102
Screening of genes involved in cAMP-mediated signalling in a large Italian series of patients affected with Albright hereditary osteodystrophy and/or Pseudohypoparathyroidism
ea0035p103
Neurological manifestations of vitamin D deficiency, is there any significant clinical correlation?
ea0035p104
Brown tumor in a patient with ectopic mediastinal parathyroid adenoma: a case report
ea0035p105
Biochemical response and imaging changes in 99mtc-mibi in patiens with primary hyperparathyroidism treated with Cinacalcet
ea0035p106
Reversal heart failure secondary to severe hypocalcaemia
ea0035p107
Novel mutation of the AIRE gene in Iranian patients with autoimmune polyglandular syndrome type 1
ea0035p108
Effect of vitamin D concentration on pregnancy, health of pregnant women, and newborn
ea0035p109
A case of post-operative hypoparathyroidism
ea0035p110
Bone and vitamin D status in young male patients with relapsing kidney lithiasis and hypercalciuria
ea0035p111
Surgery for primary hyperparathyroidism: a 10 years single-centre experience
ea0035p112
Severe hypomagnesemia due to long-term PPI use
ea0035p113
A novel mutation in GATA3 gene in HDR syndrome
ea0035p114
Correlations of vitamin D level with hormonal and biochemical parameters in polycystic ovary syndrome
ea0035p115
Cardiovascular view and QT interval in primary hyperparathyroidism
ea0035p116
New vitamin D less-calcemic analog affects human bone cell line and cultured vascular smooth muscle cells similar to other analogs
ea0035p117
The relationship with plasma calcium levels, metabolic syndrome, and risk parameters in overweight and obese Turkish women
ea0035p118
Levels of vitamin D in patients with various endocrine disorders
ea0035p119
Calcium metabolism in a child with type 1 diabetes mellitus and familial Mediterranean fever
ea0035p120
Retrospective evaluation of patients with primary hyperparathyroidism in Konya Meram Faculty of Medicine
ea0035p121
Frequency of BsmI polymorphism of vitamin D receptor gene and its association with 25-hydroxyvitamin D levels
ea0035p122
Correlation between 25-OH vitamin D3 and TSH concentration in population over 65: preliminary report
ea0035p123
Correlation among arm circumference index, 25-OH vitamin d3 concentration and lipid profile in patients over 65 years: preliminary study
ea0035p124
First seizure presentation in an elderly woman with primary vitamin D deficiency: a case report
ea0035p125
Primary hyperparathyroidism presented with peripheral brown tumor in the oral cavity: a case report
ea0035p126
VDR gene polymorphisms in Alzheimer's disease: pilot study
ea0035p127
Cinacalcet hydrochloride more efficiently controls serum calcium levels in mild-asymptomatic primary hyperparathyroidism without surgery criteria, as compared with surgical cases
ea0035p128
Cardio-metabolic phenotyping of patients with familiar hypocalciuric hypercalcemia
ea0035p129
The relationship between microvascular complications and vitamin D deficiency in type 2 diabetes mellitus microvascular complications and vitamin D deficiency
ea0035p130
Evaluation of biochemical cardiovascular risk factors, carotid intima media thickness, and arterial stiffness before and after surgery in patients with primary hyperparathyroidism
ea0035p131
Genu valgum in primary hyperparathyroidism in children
ea0035p132
Interdisciplinary aspects of primary hyperparathyroidism: symptomatology in a series of 100 cases (single-centre experience)
ea0035p133
Serum 25-hydroxyvitamin D deficiency in acute cerebral strokes' patients with and without carbohydrate metabolism disturbances in North-Eastern part of Poland
ea0035p134
Estimation of optimal serum levels of 25-hydroxyvitamin D in a cohort of HIV-infected patients
ea0035p135
Functional parathyroid cyst: a rare cause of hypercalcemia
ea0035p136
Effects of nutritional intervention program on vitamin D serum levels in adolecents
ea0035p137
Acute pancreatitis as the presenting feature and metabolic encephalopathy during the course of newly diagnosed primary hyperparathyroidism
ea0035p138
Ghrelin may have a role in obesity pathogenesis in patients with vitamin D deficiency
ea0035p139
Prospective evaluation of endocrine complications in adults with X-linked hypophosphatemic rickets
ea0035p140
Vitamin D deficiency prevalence before and after sleeve or bypass in morbid obesity
ea0035p141
Vitamin D deficiency in Russian pregnant women and risk for gestational diabetes
ea0035p142
Variety of vitamin D receptor gene polymorphisms and serum levels of vitamin D in patients with type 1 diabetes
ea0035p143
Recurrent post-surgical hyperparathyroidism: think of CYP 24A1 mutations!
ea0035p144
The association between vitamin D deficiency and metabolic parameters in pediatric obesity is influenced by what surrogate index of sunlight exposure is used
ea0035p145
Three patients with idiopathic hypoparatiroidism presented with different clinical manifestations
ea0035p146
Hypoparathyroidism and celiac disease a rare autoimmune disease combination
ea0035p147
Paternal isodisomy is a frequent cause of pseudohypoparathyroidism 1-b
ea0035p148
Frequency of vitamin D deficiency in pregnant diabetics
ea0035p149
Vitamin D seasonal variation of elderly people in Konya Residantal Care
ea0035p150
Oncogenic osteomalasia: a rare case due to lipoma
ea0035p151
The effect of VDR polymorphisms on serum testosterone level in aging men population
ea0035p152
The change in paratyroid hormone level by posture in primary hyperparathyroidism
ea0035p153
Postprandial blood glucose and fetuin-A are independently linked to the coronary calcification progression in patients with type 2 diabetes
ea0035p154
Denosumab increases bone mineral density in primary hyperparathyroidism treated with Cinacalcet
ea0035p155
Vitamin D in men with metabolic syndrome with low or normal testosterone levels
ea0035p156
Is parathyroid hormone venous sampling useful? Correlation of parathyroid hormone selective venous sampling and histopathological results in patients who underwent parathyroidectomy between 2006 and 2013
ea0035p157
Evaluation of the relationship between vitamin D concentration and selected clinical and biochemical features in women with polycystic ovary syndrome
ea0035p158
Hypercalcaemia presenting as hyperemesis gravidarum in a pregnant patient
ea0035p159
PARADIGHM: a natural history registry for patients with chronic hypoparathyroidism
ea0035p160
Cinacalcet in the treatment of primary hyperparathyroidism
ea0035p161
Hypocalcemia caused by type 1b pseudohypoparathyroidism
ea0035p162
Persistant hypercalcemia due to an atypically localised parathyroid adenoma in a patient operated from parathyroid carcinoma: a report of case
ea0035p163
The child with Di George syndrome born to a mother with primary hypothyroidism diagnosed during pregnancy
ea0035p164
Evaluation of vitamin D concentration in a population of young, healthy women: effects of vitamin D supplementation
ea0035p165
Do Lithuanian military conscripts suffer from hypovitaminosis D?
ea0035p166
Unusual case of intrathyroid parathyroid hyperplasia revealed by parathyroid hormone determination in fine-needle aspirate, co-existing with multifocal papillary thyroid carcinoma
ea0035p167
Vitamin D deficiency and tuberculin skin test reaction in old age home residents in Romania
ea0035p168
Cardiovascular Endocrinology & Lipid Metabolism
Cardiothyreosis: pathogenic conjectures, clinical aspects and surgical approach
ea0035p169
Polyphenol-rich dark chocolate lowers LDL oxidation without affecting high-sensitivity CRP levels in adults
ea0035p170
Osteopontin, hs-CRP levels in gestational diabetes mellitus
ea0035p171
Isotretinoin effect on osteopontin, hs-CRP, insulin sensitivity and CIMT in acne patients
ea0035p172
New vitamin D less-calcemic analog affects human bone cell line and cultured vascular smooth muscle cells similar to other analogs
ea0035p173
Oxytocin prevents cardiomyocyte hypertrophy
ea0035p174
Parameters of metabolic syndrome in prehypertensive subjects: should we be looking for them?
ea0035p175
Serum and plasma aldosterone levels and the respective aldosterone/plasma renin indices in healthy blood donors
ea0035p176
Red wine increases SHBG production by HepG2 cells
ea0035p177
New possible predictors of left ventricular hypertrophy
ea0035p178
Characteristics of compensated hypogonadism in patients with sexual dysfunction
ea0035p179
Blood levels of apelin in patients with essential hypertension and type 2 diabetes mellitus and its relationship with the duration of hypertension and anthropometric indices
ea0035p180
Adherence to treatment in hypertension and diabetes
ea0035p181
Evaluation of lipid levels in familial hypercholesterolemia in a lipid unit
ea0035p182
Association between serum thyrotropin levels and insulin resistance in euthyroid patients
ea0035p183
Features of patients with familial hypercholesterolemia treated in a specific lipid unit
ea0035p184
Bariatric surgery effects in lipids levels
ea0035p185
Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals
ea0035p186
Metabolic outcomes in childhood cancer survivors
ea0035p187
The associations between parathyroid hormone level and coronary artery diseases in subjects without significant renal dysfunction
ea0035p188
Serum cholesterol concentration and prevalence, awareness, treatment, and control of high LDL cholesterol in the Korea National Health and Nutrition Examination Surveys 2008-2010
ea0035p189
Anomalies of the lipid balance in hypothyroidism: comparative study by sex
ea0035p190
The pericarditis in the hypothyroidism
ea0035p191
Vascular calcification: differences between atherosclerotic changes and media sclerosis? A pilot study
ea0035p192
Apelin as a marker of an insulin resistance in patients with essential hypertension
ea0035p193
Insulin dynamics and its associated signalling pathways in equids predisposed to laminitis
ea0035p194
Laminitis: finding the key to predisposition of the metabolic disorder affecting the hoof in equids
ea0035p195
Fetuin-A as a marker of cardiovascular risk in patients with type 2 diabetes
ea0035p196
Osteoprotegerin as a marker of myocardial damage in patients with type 2 diabetes and acute coronary syndrome
ea0035p197
Epigenetic control of renin-angiotensin-aldosterone system in hypertrophic heart
ea0035p198
Occurrence of hipothyreosis in patients with metabolic syndrome
ea0035p199
Flexibility of ectopic lipids in physically active, healthy individuals
ea0035p200
Low testosterone syndrome protects from major adverse cardiovascular events in subjects at high cardiovascular burden
ea0035p201
Serum homocysteine levels are decreased in levothyroxine-treated women with autoimmune thyroiditis
ea0035p202
ARR screening using IDS-iSYS aldosterone and direct renin: effects of medication in essential and renovascular hypertension, Cushing's syndrome and primary aldosteronism
ea0035p203
eNOS, p22 phox, CETP and ER[alpha] gene polymorphisms related to metabolic-endocrine parameters in postmenopausal women with metabolic syndrome: a population based study
ea0035p204
Identification of 4 statin benefit groups according to NHLBI ATP IV criteria among Venezuelan women: EEM-lipid study
ea0035p205
Alterations in ambulatory blood pressure monitoring are frequent and associated to cardiovascular risk factors in patients with type 1 diabetes
ea0035p206
Flaccid penile acceleration as a marker of cardiovascular risk in men without classical risk factors
ea0035p207
Total and HDL-cholesterol are lower in lean PCOS women
ea0035p208
LDL cholesterol is higher in overweight and obese PCOS women
ea0035p209
Clinical case reports Pituitary/Adrenal
Diabetes insipidus and hypopituitarism in a patient with idiopathic pulmonary fibrosis
ea0035p210
Can bexarotene be a candidate drug for the medical therapy of Cushing's syndrome?
ea0035p211
Familial 46, XY gonadal dysgenesis
ea0035p212
Comorbidity of gastrointestinal stromal tumor and pituitary macroadenoma in patient referred with gastrointestinal bleeding
ea0035p213
New-onset autoimmune disorders after successful treatment of Cushing's disease
ea0035p214
An unusual clinical presentation of Sheehan's syndrome: Co-occurrence of bycitopenia, acute colonic pseudo-obstruction and acute renal failure
ea0035p215
Challenges in the diagnosis of pheochromocytoma: a case report
ea0035p216
A huge metastatic adrenocortical carcinoma presenting with Cushing's syndrome and inferior vena cava thrombosis: case report
ea0035p217
Synchronous acromegaly and gastrointestinal stromal tumor: a case report
ea0035p218
Cognitive impairment in a patient with a TART syndrome
ea0035p219
Neuropsychiatric aspects in a rare case of hypothalamic obesity
ea0035p220
A case with APECED syndrome
ea0035p221
Hyponatremia as a first symptom of hypopituitarism in an adult patient with natural history of craniopharyngioma undiagnosed since childhood
ea0035p222
Ineffectiveness of temozolomide in aggressive dopamine-agonist resistant prolactinoma and type 3 silent somatotropinoma
ea0035p223
Cushing's disease in patient with primary empty sella
ea0035p224
Temozolomide-induced marked regression of invasive Crooke's cells corticotropinoma in patient with Cushing's disease
ea0035p225
Treatment of aggressive corticotropinoma with temozolomide and bevacizumab in patient with Nelson's syndrome
ea0035p226
Meningitis coexisting with pituitary macroadenoma: report of two cases
ea0035p227
Primary hyperaldosteronism presenting as hypokalemic periodic paralysis: two case reports
ea0035p228
A case of hypopituitarism caused by lung cancer metastasis to the pituitary
ea0035p229
Transient severe polyuria in a patient with bilateral pheochromocytoma after adrenalectomy
ea0035p230
Macroprolactinoma that disappears in a short time with cabergoline treatment: case report
ea0035p231
A case of primary aldosteronism with the subclinical Cushing's syndrome examined the localization by double immunostaining for CYP11B1 and B2
ea0035p232
Primary thyroid lymphoma in a patient with adrenal incidentaloma
ea0035p233
Takotsubo cardiomyopathy triggered by pheocromocytoma crisis
ea0035p234
A history of 30 years severe uncontrolled hypertension: Conn's syndrome
ea0035p235
Unusual cause of hypoglycemia in a type 2 diabetic patient: panhypopituitarism
ea0035p236
Hyperprolactinemia secondary to primary hypothyroidism with hyperplasia pituitary
ea0035p237
A rare cause of primary hyperaldosteronism unilateral adrenal hyperplasia: case report
ea0035p238
Clinical case of pituitary apoplexy due to hemorrhagic vasculitis
ea0035p239
Temporary adrenal failure due to tuberculosis: a rare phenomenon in recent years
ea0035p240
Malignant feminising adrenal tumor without gynecomastia
ea0035p241
Congenital panhipopituitarism and ectopic posterior pituitary
ea0035p242
A case report: functioning cystic pheocromocytoma
ea0035p243
Primary adrenal failure due to primary antiphospholipid syndrome
ea0035p244
Catecholamine resistance hypotension after pheochromocytoma resection
ea0035p245
Prepubertal male gynecomastia-issues of diagnosis
ea0035p246
Spindle cell oncocytoma: a new presentation of a rare disease
ea0035p247
A primary adrenal adenomatoid tumor in a young woman
ea0035p248
Infected giant cystic phaeochromocytoma masquerading as a hepatic abscess
ea0035p249
Hyponatremia and diabetes insipidus: a case report
ea0035p250
Primary hyperthyroidism following successful surgical treatment for secondary hyperthyroidism due to TSH-secreting pituitary adenoma
ea0035p251
A case of addison's disease associated with ankylosing spondylitis
ea0035p252
A case report: posterior pituitary evaluated as microadenoma in the magnetic resonance imaging
ea0035p253
Acromegaly accidentally diagnosed: a typical course of the disease
ea0035p254
Diabetes insipidus as the primary symptom of infundibuloma
ea0035p255
An unusual case of reversible empty sella
ea0035p256
Acromegaly with a normal pituitary gland
ea0035p257
Different courses of Carpenter syndrome
ea0035p258
Hyporeninemic hypoaldosteronism with severe hyperkalemia following adrenalectomy for primary hyperaldosteronism : a case report
ea0035p260
Clinical case reports Thyroid/Others
A new mutation associated with pseudohypoparathyroidism? two case reports
ea0035p261
Prevalence of thyroid abnormalities among psoriatic patients
ea0035p262
Coexisting hurthle cell neoplasm and thyroid hormone resistance
ea0035p263
Primary hyperparathyroidism with severe hypercalcemia during pregnancy
ea0035p264
Acute necrotizing pancreatitis as first manifestation of primary hyperparathyroidism
ea0035p265
Is repeated fine needle aspiration expedient when the first one is nondiagnostic
ea0035p266
Analysis of 40 696 FNAB of thyroid nodules performed in one center
ea0035p267
Functional results of inadvertent parathyroid excision during thyroid surgery
ea0035p268
Scleredema diabeticorum in a nonregulated type 2 diabetic patient
ea0035p269
Rare coexistence of familial mediterranean fever and familial partial lipodystrophy: presented as acute pancreatitis due to severe hypertriglyceridemia
ea0035p270
Localized Aspergillus thyroiditis in patients with diabetic nephropathy
ea0035p271
Drug-induced syndrome of inappropriate antidiuretic hormone secretion
ea0035p272
Heparin-induced hyperkalaemia in a patient with type 2 diabetes: a case report
ea0035p273
A rare variant of papillary carcinoma of thyroid: Warthin-like variant
ea0035p274
Mixed medullary and papillary carcinoma of thyroid
ea0035p275
Morphological and functional imaging allow better characterization of brown tumors in a patient with severe primary hyperparathyroidism
ea0035p276
When mother and daughter become father and son
ea0035p277
Giant mediastinal parathyroid cyst with hyperparathyroidism: a case report
ea0035p278
Three endocrine neoplasms: an unusual combination of pituitary adenoma, papillary thyroid carcinoma, and follicular thyroid carcinoma
ea0035p279
Not a make-up, but an alarm signal of a new onset of Addison's disease
ea0035p280
A carotid body tumor mimicking a thyroid nodule: a case report
ea0035p281
An uncommon infiltrative disease of thyroid: Riedel's thyroiditis
ea0035p282
Primary hyperparathyroidism due to parathyroid carcinoma: case report
ea0035p283
A rare cause of hypocalemia: familial hypoparathyroidism
ea0035p284
The coexistence of anaplastic thyroid carcinoma and papillary thyroid carcinoma: two case reports
ea0035p285
One month-Tadalafil 5 mg once daily administration improves clinical and ultrasound parameters of chronic pelvic pain syndrome/lower urinary tract symptoms
ea0035p286
Recurrent episodes of hypoglycemia caused by insulinoma in a patient with type 2 diabetes mellitus
ea0035p287
Primary hyperparathyroidism due to ectopic mediastinal parathyroid gland at the level of anterior wall of ascending aorta
ea0035p288
Rhabdomyolysis precipitated acute renal injury during levothyroxine withdrawal for remnant ablation in a case with papillary thyroid cancer
ea0035p289
46,XX/47,XXY mosaic form of klinfelter syndrome with ambiguous genitalia: a case report
ea0035p290
Primary hyperparathyroidism caused by mediastinum located ectopic parathyroid adenoma resected by video-assisted thoracic surgery
ea0035p291
Insulinoma and pregnancy: a case report
ea0035p292
Excessive stimulation of TSH receptor during pregnancy
ea0035p293
Brown tumors: the first and the final manifestation of primary hyperparathyroidism.
ea0035p294
Oncocytic carsinoma with sternum metastasis
ea0035p295
Type 2 polyglandular autoimmune syndrome and Turner syndrome
ea0035p296
Thyroid squamous cell carcinoma
ea0035p297
Patient with alopecia areata
ea0035p298
Breast cancer in multiple endocrine neoplasia type 1
ea0035p299
Congenital TBG production disorder
ea0035p300
Ectopic lingual thyroid gland: two case report
ea0035p301
An unusual case of diabetes mellitus as a result of heterozygous missense mutation R482W in LMNA gene (familial partial lipodystrophy type 2), described for the first time in Russian population
ea0035p302
A patient with lung ectopic parathyroid coexistent with primary hyperparathyroidism and end-stage renal diseases
ea0035p303
Graves-Basedow disease in adolescent patients with type 1 diabetes mellitus
ea0035p304
Follicular thyroid carcinoma presenting with occipital bone and lung metastasis
ea0035p305
Long-term use of tolvaptan in hyponatraemia due to SIADH in elderly
ea0035p306
Challenges in exophthalmia management: Frontal mucocele
ea0035p307
Testicular histological and immunohistochemical particularities in a post-pubertal patient with 5[alpha]-reductase type 2 deficiency
ea0035p308
Treatment of hyponatraemia with vasopressin receptor 2 antagonists (V2RA): case series
ea0035p309
Do clinical events always suggest familial form of medullary thyroid carcinoma (MTC)? - two case reports
ea0035p310
A rare case of cutaneous metastization of a differentiated thyroid carcinoma initially diagnosed as Hurthle cell adenoma
ea0035p311
Diagnosis of neonatal diabetes mellitus in the mother through the detection of hyperglycemia in her child
ea0035p312
Ectopic co-secretion of growth hormone and growth hormone-releasing hormone from a neuroendocrine lung tumor in a patient with MEN1 syndrome
ea0035p313
Refractory Graves' ophthalmopathy treated with rituximab
ea0035p314
Drug induced skin eruption in type 2 diabetes mellitus patients who treating with a dipeptidyl peptidase-4 inhibitor plus metformin
ea0035p315
Severe postmenopausal virilization of unknown origin
ea0035p316
Propylthiouracil induced lupus erythematosus in a patient with Grave's disease: a case report
ea0035p317
Monomorphic ventricular tachycardia due to primary hyperparathyroidism: a case report
ea0035p318
The unusual case of the appearance of radioiodine (I-131) uptake in lung metastases in a patient with papillary thyroid cancer (PTC)
ea0035p319
Recurrent debilitating thyroiditis
ea0035p320
Hashimoto thyroiditis followed by Grave's disease
ea0035p321
Why obesity is multifactorial? Mixture of genetic predisposition, endocrine dysfunction and environmental factors: a case report
ea0035p322
Case study in PTU-induced hepatotoxicity: a retrospective analysis of the key aspects of survivability in PTU-induced hepatotoxicity in adults
ea0035p323
Meningioma in a patient with tall cell papillary thyroid carcinoma
ea0035p324
Hypoglycemia in type 1 diabetes mellitus patient - factual ou factitious?
ea0035p325
From hemoptysis to diagnosis of congenital hypothyroidism: a diagnostic pitfall
ea0035p326
Hirata disease: a rare form of hyperinsulinemic hypoglycemia
ea0035p327
Gynecomastia: a rare etiology
ea0035p328
Two serious complications of propylthiouracil treatment in the same patient: case report
ea0035p329
Brain metastatic disease in a patient with tall cell thyroid carcinoma
ea0035p330
Thyroid papillary microcarcinoma presenting as parotid metastasis: a case report
ea0035p331
Medullary and papillary thyroid cancer metastasis in the same lymph node: case report
ea0035p332
Developmental Endocrinology
Effect of glycemia on sleep indicators for patients with type 1 diabetes mellitus
ea0035p333
Physiological expression of thyroid hormone receptors during zebrafish development and effects of their molecular disruption
ea0035p334
Clinical and molecular profile of patients with gonadal dysgenesis attending tertiary care hospital.
ea0035p335
Crystal structure of Drosophila imaginal morphogenesis protein-Late 2 (IMP-L2) in free form and bound to Drosophila insulin-like peptide 5 (DILP5) and human Insulin-like growth factor-I (hIGF1).
ea0035p337
Genome-wide survey for clinically relevant structural abnormalities contributing to pathogenesis of combined pituitary hormone deficiency (CPHD) with childhood onset.
ea0035p338
Influence of growth hormone therapeutic supplementation on early hematopoietic stem/progenitor cells in patients with growth hormone deficiency (GHD).
ea0035p339
Diabetes (epidemiology, pathophysiology)
Metformin may reduce bladder cancer risk in patients with type 2 diabetes
ea0035p340
Exenatide protects pancreatic islets against brain death-induced inflammation and viability loss
ea0035p341
Higher HDL cholesterol to apolipoprotein A-I ratio is protective against the development of type 2 diabetes
ea0035p342
Relationship between age and Hba1c in Turkish patients
ea0035p343
Features and outcome of stroke related to type 2 diabetes mellitus (T2DM) in a community hospital
ea0035p344
CTRP3 increased the insulin sensitivity of 3T3-L1 adipocyte via decreasing the expression of inflammation factors
ea0035p345
Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus
ea0035p346
Risk of diabetes mellitus after first-attack acute pancreatitis: a national population-based study
ea0035p347
Low rates of attaining LDL goals despite statin use in diabetic patients in a tertiary healthcare center.
ea0035p348
Profile of type 2 diabetic patients according to HbA1c tertiles in our tertiary health care center
ea0035p349
Clinical case of type 1 diabetes mellitus and multiple sclerosis - just bad luck?
ea0035p350
A rare presentation of type 2 diabetes: diabetic ketoacidosis, acute pancreatitis, and hypertriglyceridaemia
ea0035p351
The TLR3 rs3775291 and rs13126816 polymorphisms are associated with risk for developing T1DM
ea0035p352
Association between Asp299Gly and Thr399Ile polymorphisms in TLR4 gene and type 2 diabetes mellitus: Case-control study and meta-analysis
ea0035p353
Age and gender characteristics of carbohydrate metabolism disorders in dependance on HbA1c level
ea0035p354
Prevalence of bronchial asthma in patients with type 2 diabetes mellitus
ea0035p355
Prevention of cardiovascular lesions by active detection of diabetes mellitus
ea0035p356
Screening on type 2 diabetes mellitus incidence in Tashkent
ea0035p357
Epidemiology of type 1 diabetes mellitus in children in Uzbekistan
ea0035p358
The rs1746661 polymorphism in the FNDC5 (Irisin) gene is associated with increased levels of total cholesterol in white patients with type 2 diabetes mellitus
ea0035p359
Atherosclerosis in patients with prediabetes and type 2 diabetes is associated with more significant microcirculation abnormalities
ea0035p360
Relationship between indices of nutriture among residents of a Coastal City in South East Nigeria
ea0035p361
Pregnancy outcomes in women with gestational diabetes
ea0035p362
Intensive and expensive new treatments or better education for patients with diabetes: Where should we begin with?
ea0035p363
Does systematic error in the HbA1c measurement matter when locally analyzed HbA1c is used for benchmarking in a national diabetes register?
ea0035p364
UCP1, UCP2 and MnSOD expression in pancreas from brain-death subjects: A case-control study
ea0035p365
Association between UCP polymorphisms and BMI changes: A cross-sectional study and meta-analysis
ea0035p366
Serum cytokines and proinflammatory markers in first degree relatives of patients with type 1 diabetes
ea0035p367
Increased prevalence of anti-thyroid and anti-gastric parietal cell antibodies in first degree relatives of patients with type 1 diabetes
ea0035p368
Sexual function of 26-36-year-old men with type 1 diabetes
ea0035p369
Compensatory increased irisin levels in gestational diabetes mellitus
ea0035p370
GCK-MODY caused by a new mutation in the GCK gene
ea0035p371
Branched-chain and aromatic amino acid plasma concentration as a markers of metabolic syndrome
ea0035p372
Acromegaly treatment and carbohydrate metabolism disturbances
ea0035p373
New onset T1DM after vaccination for measles: Coincidence or consequence?
ea0035p374
Adipokines, insulin resistance in early pregnancy and risk for gestational diabetes
ea0035p375
Prevalence of androgenic deficit in men with metabolic alterations
ea0035p376
Assessment of relaxin levels in pregnant women with gestational diabetes mellitus
ea0035p377
Low serum 25(0H) vitamin D3 concentration is associated with increased accumulation of advanced glycation endproducts (AGEs) in the skin of patients with type 1 diabetes
ea0035p378
Mean platelet volume reflects framingham risk score in intermediate hyperglycemia
ea0035p379
Anthropometric and biochemical parameters in older women with a history of gestational diabetes
ea0035p380
Changes of sphingolipid profiles in serum of patients with diabetes
ea0035p381
Iranians face with the same barriers to diabetes self management as people in other parts of the world. Need for family support
ea0035p382
Low apelin levels are associated with a marked increase in risk for development of the gestational diabetes mellitus
ea0035p383
Translating the A1C assay into estimated average fasting glucose values: Data from the 2011 Korea National Health and Nutrition Examination Survey V
ea0035p384
Presence of erythrocytosis in a patient with concomitant type 1 diabetes mellitus and Gitelman syndrome
ea0035p385
Incidence of type 1 diabetes mellitus over 21 consecutive years among 15-39-year aged Lithuanian population
ea0035p386
The HLA-A*33 haplotype enhances the risk of type 1 diabetesin ndividuals with HLA-DR3+ or DR9+ haplotype
ea0035p387
What is the contribution of MODY gene polymorphisms in the development of gestational diabetes mellitus?
ea0035p388
Characterization of severe hypoglycemia episodes evaluated in the emergency department of a central hospital
ea0035p389
Characterization of the episodes of severe hypoglycemia evaluated by a pre-hospital care unit of a reference hospital
ea0035p390
Vitamin D, insulin dependency and BMI in type 1 diabetes
ea0035p391
Resistin mRNA expression in fat and placental tissue of patients with gestational diabetes
ea0035p392
Clinic blood pressure shows low sensitivity to detect alterations in ambulatory blood pressure monitoring in patients with type 1 diabetes
ea0035p393
Increased prevalence of hepatocellular carcinoma in patients with cirrhosis and insulin resistance candidate to liver transplantation
ea0035p394
Alterations in ambulatory blood pressure monitoring are associated to proinflammatory cytokines in patients with type 1 diabetes
ea0035p395
Vitamin D and diabetes mellitus type 2
ea0035p396
Features of patients with LADA in a Diabetes Unit
ea0035p397
Paper of oxidative stress and placenta on the development of gestational diabetes mellitus
ea0035p398
Evaluation of the approach to diabetic patients before the first admission to diabetologist: Is there a room for the improvement?
ea0035p399
Impact of Impaired Fasting Glucose on Blood Pressure and Vascular Risk Profile of Normotensives and Untreated Hypertensive Subjects
ea0035p400
In human retina the A allele of the [mdash]866G/A polymorphism in the UCP2 gene is associated with increased UCP2 protein concentrations
ea0035p401
Association of the UCP polymorphisms with susceptibility to obesity: case-control study and meta-analysis
ea0035p402
Diabetes complications
Does proton pump inhibitor use decrease microvascular complicaton rate in type 2 diabetic patients? A retrospective analysis
ea0035p403
The relation of left ventricular hypertrophy and markers of inflammation in type 2 diabetic patients
ea0035p404
Incidence and cost of complications among men and women with type 2 diabetes
ea0035p405
Is the ankle-brachial index directly associated with current glycemic control in diabetic patients? Preliminary results of our study
ea0035p406
Abstract unavailable
ea0035p407
Angiogenic factors and circulating endothelial progenitor cells in patients with type 2 diabetes mellitus
ea0035p408
Associated study of polymorphic variants in the gene for superoxide dysmutase (Mn SOD) and different types of diabetes mellitus
ea0035p409
Depression risk factors in type 1 diabetes mellitus
ea0035p410
Disabilities of the arm, shoulder and hand questionnaire and diabetic complications: preliminary results
ea0035p411
Relation between psychiatric symptoms and diabetic complications: preliminary results
ea0035p412
The diabetic hand: a forgotten complication?
ea0035p413
The results of evaluation of dynamics of levels of glycemia in diabetes mellitus type 1
ea0035p414
Analysis of diabetic retinopathy risk factors in type 2 diabetes patients
ea0035p415
Treatment of ulcer-necrotic manifestations of diabetic foot using ultrasonic cavitation
ea0035p416
Genetic dependence of urinary enzyme, neutral [alpha]-glucosidase, in diabetic nephropathy in uzbek children and adolescents with type 1 diabetes mellitus
ea0035p417
Activity of neutral [alpha]-glucosidase in the urine of children and adolescents with type 1 diabetes mellitus and diabetic nephropathy
ea0035p418
Prevalence and risk factors of prolonged QTc interval in type 2 diabetic patients; impact of the type of treatment and quality of glycemic control
ea0035p419
Patients with type 1 diabetes and thyroid autoimmunity have low prevalence of microangiopathic complications
ea0035p420
Relationship between diabetes mellitus and hemostasis: a prothrombotic condition
ea0035p421
Androgendeficiency in men with type 2 diabetes mellitus
ea0035p422
Characteristic features of the course of chronic venous insufficiency of the lower limbs in patients with impaired peripheral innervation of diabetes mellitus type 2
ea0035p423
Abstract unavailable
ea0035p424
Benfotiamine efficiency in the stabilization of diabetic peripheral polyneuropathy
ea0035p425
Association of angiotensin-converting enzyme gene I/D polymorphism and aldosterone synthase (CYP11B2) gene [mdash]344T/C polymorphism with the risk of nephropathy in diabetic patients
ea0035p426
Sclerostin distribution in children and adolescents with type 1 diabetes mellitus and correlation with bone metabolism markers and bone mineral density
ea0035p427
Higher levels of osteoprotegerin and S-RANKL in children and adolescents with type 1 diabetes mellitus may indicate increased osteoclast activity and predisposition to lower bone mass
ea0035p428
The association of peripheral artery disease with renal function and albuminuria in diabetic patients
ea0035p429
Low FT4 syndrome in gestational diabetes
ea0035p430
Metabolic syndrome and cardiovascular risk are less prevalent in LADA vs type 2 diabetes patients
ea0035p431
Erectile dysfunction scores are lower in type 2 diabetes mellitus but not correlate with carotis intima media ticknes or coronary arter disease
ea0035p432
Diabetic polyneuropathy as the only diabetes related complication associated with higher likelihood and more severe forms of erectile dysfunction in type 2 diabetes
ea0035p433
The influence of maternal BMI and weight gain in gestational diabetes: results of the Portuguese population in 2011
ea0035p434
Hemostatic biomarkers in selected group of patients with type 1 diabetes: are they associated with different degrees of diabetic retinopathy
ea0035p435
Markers of endothelial dysfunction in type 1 diabetics with or without microalbuminuria
ea0035p436
Skin findings among diabetic patients
ea0035p437
Vascular endothelial growth factor polymorphism +405 G/C is associated with early stage of diabetic nephropathy in patients with type 2 diabetes
ea0035p438
Analysis of ultrasound structure of the thyroid gland and assessment of structural changes in patients with diabetes mellitus type 1 at different stages of chronic kidney disease
ea0035p439
Comparative analysis of methods for the evaluation of renal function in patients with diabetes mellitus type 1 at different stages of chronic kidney disease
ea0035p440
QT intervals and vitamin D levels in diabetic patients
ea0035p441
Dental care and periodontal disease in Turkish diabetic patients
ea0035p442
Clinical profile and management of diabetic osteoarthropathy
ea0035p443
Comparative assessment of parathyroid hormone and bone turnover markers in diabetic and non-diabetic patients with end-stage chronic kidney disease
ea0035p444
Autoimmune pancreatitis after intravenous insulin desensitization in a diabetic patient allergic to insulin without pancreatic reserve
ea0035p445
A lepromatous lepra case presented like diabetic foot
ea0035p446
Prolonged cerebellar ataxia after: severe hypoglycemic attack in a patient with T1DM: a rare but disturbing sequela
ea0035p447
Mean platelet volume in type 2 diabetic patient: is there a relationship between mean platelet volume and diabetic microvasculary complications?
ea0035p448
Small fibre neuropathy association with increased mortality in patients with chronic kidney disease, with or without diabetes mellitus
ea0035p449
Diabetic neuropathy in a young patient with recently diagnosed diabetes mellitus: an atypical presentation of insulin neuritis
ea0035p450
Abstract unavailable
ea0035p451
Associations of serum lipid levels with diabetic retinopathy in type 1 diabetics
ea0035p452
Effect of diabetic nephropaty on lipid profiles of adult type 1 diabetics
ea0035p453
Vasoinhibins are natural inhibitors of angiogenesis in the vitreous and are impaired in patients with diabetic retinopathy
ea0035p454
The correlation of foetal ultrasound and HbA1c with birth weight in women with gestational diabetes
ea0035p455
Undiagnosed diabetes mellitus presenting as thrombosis of the portal venous system: case report
ea0035p456
Diabetic ketoacidosis and olanzapine: case report
ea0035p457
Intima: media thickness and endothelial dysfunction in GCK and HNF1A MODY patients
ea0035p458
Prevalence of gastrointestinal diseases in the newly diagnosed pre-diabetic and diabetic patients
ea0035p459
The influence of type 2 diabetes mellitus on periodontal disease
ea0035p460
Diabetes and end-stage renal disease: clinical evaluation of diabetic renal transplant candidates
ea0035p461
Diabetes therapy
The role of the community pharmacist in managing patients with diabetes type 2
ea0035p462
Trends of oral anti-diabetic drug usage amongst general practitioners of North-East India: an audit
ea0035p463
The outcome of [beta] cell function after early insulin therapy in the recently diagosed type 2 diabetes (in Egyptian population) our experience in EL-Minia university hospital
ea0035p464
Metabolic control of our turkish diabetic patients on exenatide therapy: good at metabolic control but how about compliance?
ea0035p465
Effect of 7 weeks endurance exercise on insulin resistance and RBP4 protein expression in liver and adipose tissue in type 2 diabetic rats
ea0035p466
Diabetic ketoacidosis simulator: a new learning tool for a life threatening condition
ea0035p467
Does statin use impairs glycaemic control in type 2 diabetic patients? A retrospective analysis
ea0035p468
Effect of angiotensin receptor blockers on glycaemic control in type 2 diabetic patients? A retrospective analysis
ea0035p469
Comparison of angiotensin receptor blockers and angiotensin converting enzyme inhibitors for glycaemic regulation
ea0035p470
Potential role of state of zinc metabolism in biguanides efficiency in hypoglycemic therapy
ea0035p471
Repetetive training of diabetic patient for medical nutrition and insulin therapy can improve the metabolic control
ea0035p472
Study on pregnancy outcomes in patients with type I diabetes mellitus having self-control skills
ea0035p473
Is psychological support the missing ingredient in successful outcomes for pancreas transplantation: the importance of recognising and managing the 'competitive patient'
ea0035p474
Improvement of HbA1c is blunted following discontinuation of an on-line telemonitoring system, in patients with inefficiently controlled insulin-treated diabetes mellitus
ea0035p475
Could favorable effects of liraglutide on steato-hepatitis be independent of weight loss in type 2 diabetes? A case report
ea0035p476
Embryonal antitumor modulator's preventive action on streptozotocin induced damage of mouse pancreatic [beta] cells in primary culture
ea0035p477
Hypogonadal men with cardiovascular diseases benefit from long-term treatment with testosterone undecanoate: observational data from a registry study
ea0035p478
Gastric contractility modulation: a novel method for the treatment of type 2 diabetes mellitus with overweight and obesity: a preliminary results of the clinical study
ea0035p479
The role of continuous subcutaneous insulin infusion therapy in a case of Seip-Berardinelli congenital lipodystrophy
ea0035p480
Type 2 diabetic patients can benefit by switching from premixed insulin analogues to detemir and aspart insulin
ea0035p481
Prospective study of healthy lifestyle on diabetes mellitus
ea0035p482
Self-monitoring of blood glucose and perceived obstacles in Turkish patients with diabetes mellitus
ea0035p483
Normal and extended release form of metformin in type 2 diabetic and pre-diabetic patients.
ea0035p484
Teaching system of self-control in endocrinology
ea0035p485
Treatment with dipeptidyl peptidase-4 inhibitors may induce bullous pemphigoid in patients with type 2 diabetes
ea0035p486
Changes in insulin sensitivity and DHEAS in type 2 diabetic men treated with liraglutide
ea0035p487
Basal bolus insulin therapy in hospitalised patients with diabetes mellitus type 2 using two algorithms embedded in a tablet PC
ea0035p488
Influence of different modes insulin on carbohydrate metabolism, state transplant, control of metabolic and hemodynamic factors in patients with type 1 diabetes during the 1st year after kidney transplantation
ea0035p489
The effects of metformin therapy on bone resorption and bone formation markers in newly diagnosed patients with type 2 diabetes mellitus
ea0035p490
The favourable effects of autologous hematopoietic stem cell transplantation on the immune system in patients with type 1 diabetes
ea0035p491
The effect of continuous subcutaneous insulin infusion therapy on acute complications and pregnancy outcome in pregnant women with type 1 diabetes mellitus
ea0035p492
Effect of omega-3 polyunsaturated fatty acids on insulin resistance in type 2 diabetes
ea0035p493
Inhibition of SGLT using Ca2+-zeolite and preserve the periphery of glucose excess
ea0035p494
Efficacy of acarbose in different geographical regions of the world: analysis of a real-life database
ea0035p495
Evolution of ambulatory blood pressure monitoring in a cohort of patients with type 1 diabetes after 7 years
ea0035p496
The evaluation of the long-term effect of insulin pump therapy in children with type 1 diabetes mellitus
ea0035p497
Insulin infusers: 8 years experience
ea0035p498
Differential effects of native Peptide YY and its long acting analogue (Y-59) on innate lymphocyte function and anti-tumour activity
ea0035p499
Liraglutide effects on glycaemic control, body weight, blood pressure and lipid profile in obese patients with type 2 diabetes: real-life clinical practice
ea0035p500
Is there a relationship between body composition and insulin regimen modality in type 1 diabetic patients?
ea0035p501
Endocrine disruptors
Acute exposure of BPA from electronic gadgets does not induce oxidative stress in the rat's brain
ea0035p502
The reproductive toxicity of butyl benzyl phthalate in male rabbits: the possible protective role of flaxseed
ea0035p503
Treatment with kaempferol resulted in the regulation of cell cycle-related and apoptosis-related genes in cancer cell growth caused by triclosan in MCF-7 breast cancer cells
ea0035p504
Treatment of prostate cancer cells with phthalate resulted in the upregulation of cyclin D1 and c-myc and downregulation of p21 via estrogen receptor signaling pathway in the progression of LNCaP prostate cancer cells
ea0035p505
Treatment of breast cancer cells with triclosan and octylphenol altered the expressions of cyclin D1 and p21 and induced breast tumor masses via an estrogen receptor-dependent signaling pathway in cellular and mouse xenograft models
ea0035p506
Transcriptional levels of aryl-hydrocarbon receptor, aryl-hydrocarbon receptor dependent- and cell cycle-related genes were altered by fenhexamid in human ovarian cancer cells expressing estrogen receptors
ea0035p507
Transcriptions of cell cycle-related genes were altered by benzylbutyl phthalate and diisobutyl phthalate via an estrogen receptor [alpha] signaling pathway in human ovarian cancer cells
ea0035p508
Estrogen and bisphenol A affect enamel formation by different signaling pathways
ea0035p509
Organometric parameters of rat's adrenal glands after 60-day administration of sodium benzoate and application of mexidol
ea0035p510
The potential role of bisphenol A in the pathogenesis of polycystic ovary syndrome
ea0035p511
Bisphenol A disrupts seminoma cell proliferation following an inverted U-shaped non monotonic dose-response curve, due to its greater affinity for GPR30, the non classical membrane G protein-related estrogen receptor, than for ER[beta]
ea0035p512
Di-ethylhexyl-phthalate is metabolised by human thyroid cells and may influence thyroglobulin secretion
ea0035p513
Endocrine tumours and neoplasia
Novel and classical molecular pathways identified in pituitary tumorigenesis using mRNA profiling
ea0035p514
Our experience in the evaluation criteria used for the genetic study of patients suspected of being affected by multiple endocrine neoplasia type 1 and mutational spectrum
ea0035p515
The truncated somatostatin receptor sst5TMD4 stimulates the production of pro-angiogenic factors in in vitro and in vivo breast cancer models
ea0035p516
The effects of cAMP in different neuroendocrine tumorous cells: the role of Epac and PKA in cell proliferation and cell adhesion
ea0035p517
Molecular mechanisms of unexpected promoting effects of progesterone and mifepristone on granulosa cell tumorigenesis
ea0035p518
BRAF V600E mutation in washing liquid of thyroid fine-needle aspiration: a surprising tool in cytological benign nodules
ea0035p519
Classic ductal sonographic criteria vs real-time elastography criteria in diagnosing nodular breast lesions
ea0035p520
A case of insulinoma localized in pancreas tail that cannot be monitored with endosonography and abdominal MR but with contrast abdominal BT
ea0035p521
Adrenocortical carcinoma: a review of four cases
ea0035p522
A rare case of an androgen-producing stromal luteoma of the ovary in a postmenopausal woman, diagnosed by means of selective venous blood sampling
ea0035p523
Fnab and calcitonin wash-out during exenatide therapy
ea0035p524
The presence of B-RAF V600E and K601E mutations in our Ligurian population
ea0035p525
The use of demeclocyclin in the syndrome of paraneoplastic inappropriated secretion of anti-diuretic hormone: about one observation
ea0035p526
Could non-functional adrenal incidentaloma be a risk factor for atherosclerosis and metabolic disturbances?
ea0035p527
Retrospective evaluation of adrenal incidentalomas in a tertiary care institution
ea0035p528
A rare ovarian carcinoma
ea0035p529
Clinical management of insulinomas: a single institution's experience
ea0035p531
Comparison of chromogranin A levels in serum and plasma (EDTA2K) and the respective reference ranges in healthy males
ea0035p532
High JAG1 expression in adrenocortical carcinomas is associated with better prognosis
ea0035p533
Role of metformin on recurrence-free survival in neuroendocrine tumors
ea0035p534
Expression of inhibitor of apoptosis protein BIRC7/livin in adrenocortical tumors
ea0035p535
Aurora kinases inhibitors Vx-680, SNS314 and ZM447439 in adrenocortical tumors
ea0035p536
Sunitinib induced hypocalcaemia during treatment of pancreatic neuroendocrine tumours
ea0035p537
Cyclin D1 levels are involved in the resistance to m-TOR inhibitors in human bronchial carcinoids
ea0035p538
Follicular lesion of undetermined significance in thyroid nodules fine needle aspiration cytology: a revision of 95 cases
ea0035p539
Monitoring of pheochromocytomas development in proto-oncogene RET mutation's carriers
ea0035p540
Efficiency of ultrasound-guided percutaneous thyroid nodule biopsy among patients hospitalized in the department of internal medicine
ea0035p541
Multiple endocrine neoplasia type 1 and 2: a retrospective study
ea0035p542
The prevalence of malignancy in thyroid incidentalomas in an iodine-replete area
ea0035p543
A major Endocrine Unit's experience: the combined role of ultrasound scans and fine needle aspiration in the management of thyroid nodules
ea0035p544
Ultrasonography as a first-line investigation of thyroid nodule: is it still the case? An audit to examine and reflect on our practice in a regional endocrine unit
ea0035p545
Pheochromocytoma and neurofibromatosis type 1: description of case
ea0035p546
Ganglioneuroma of the adrenal gland: a case report
ea0035p547
Efficacy and safety of transarterial chemoembolization of unresectable neuroendocrine liver metastases
ea0035p548
Efficacy of lanreotide autogel in men1-related gastrinomas: a case series
ea0035p549
The effectiveness of yttrium90/lutetium177-labeled somatostatin analogues treatment in functional pNETs
ea0035p550
Evaluation of vegf and endocan/esm-1 expression in pnets and correlation with Ki67 and prognosis
ea0035p551
Insulinoma, recurrent hypoglycaemia: a debilitating condition
ea0035p552
Gastro-entero-pancreatic neuroendocrine tumors (GEPNETs) - 10 year experience of one center
ea0035p553
Epidemiology of gastro-entero-pancreatic neuroendocrine tumors in Krakow and Krakow district area
ea0035p554
Factors influencing survival of patients diagnosed with gastro-entero-pancreatic neuroendocrine tumors in Krakow and Krakow district area
ea0035p555
Catecholamin crisis as a first manifestation of multiple endocrine neoplasia type 2A
ea0035p556
Adrenal incidentaloma: is it a disease of elderly? A clinical study of 2650 cases registered at a single endocrinological center
ea0035p557
Abstract unavailable
ea0035p558
Evaluation of demographic data of patients with adrenal incidentalomas
ea0035p559
Expression of FSH hormone receptors in pituitary adenomas: a marker of tumour aggressiveness?
ea0035p560
Malignacy prevalance and related conditions in adrenal incidetaloma
ea0035p561
Consolidation treatment with somatoatatin analogues after radiopeptide therapy
ea0035p562
Analysis of ultrasonographic parameters influencing thyroid nodules elasticity
ea0035p563
Differential TNF[alpha] and Toll-like-receptor 4-signaling in endocrine tumors after tumor- vascular- disrupting Agent ASA404 (Vadimezan) and TNF[alpha] treatment
ea0035p564
Effect of thiazolidinediones: PPAR[gamma] agonists on hormones secretion by cells of human adrenocortical cancer in vitro
ea0035p565
Primary neuroendocrine carcinoma of renal: a rare case report
ea0035p566
Neuroendocrine carcinomas of the thymus: two case reports
ea0035p567
Expression of prolactin receptor in aldosterone-producing adrenal adenomas
ea0035p568
Patient with dissemination of neuroendocrine neoplasm of unknown origin and carcinoid syndrome: diagnostic and therapeutic difficulties
ea0035p569
Uncertain clinical prognosis of pancreatic neuroendocrine tumour: case report
ea0035p570
Androgens regulate gene expression of glucose transporters and glycolytic enzymes in prostate cancer cells
ea0035p571
Peptide receptor radionuclide therapy as neoadjuvant treatment
ea0035p572
CD56 immunohistochemical expression: a useful tool for the diagnosis of in thyroid carcinomas of follicular origin
ea0035p573
A clinical case of effective treatment of giant prolactinoma in patient with morbid obesity
ea0035p574
Chemoembolization as a locoregional treatment for metastatic disease on a liver transplant from a bronchial carcinoid neuroendocrine tumor
ea0035p575
Correlation between atypical pituitary adenomas and Ki-67 Li: clinical and prognostic aspects
ea0035p576
Patient-reported outcomes associated with lanreotide Autogel (LAN-ATG) for symptom control of carcinoid syndrome in gastroenteropancreatic neuroendocrine tumour patients: results of SYMNET, a large International Multicentre Observational Study
ea0035p577
Antiproliferative effects of lanreotide Autogel in patients with enteropancreatic neuroendocrine tumours: results of CLARINET, a large international phase 3 study
ea0035p578
Efficacy and safety of lanreotide Autogel treatment for carcinoid syndrome in patients with gastroenteropancreatic neuroendocrine tumors: results of ELECT, a large multinational phase 3 study
ea0035p579
Plasma free metanephrine, normetanephrine and 3-methoxytyramine for the differential diagnosis of pheochromocytoma and paraganglioma
ea0035p580
Is early repeat surgery a feasible concept for potential incomplete resection in acromegaly?
ea0035p581
Eleven base pair (AACACTCTAGC) deletion of SDHB Ex-4 from c.325 to c.335 in the patient with malignant Vaginal Paraganglioma - A case report
ea0035p582
99mTc-GLP-1 scintigraphy, an efficient method for the detection of insulinoma: results of 3 years' experience
ea0035p583
The first experience of video-assisted resection of the thyroid gland in the Republic of Kazakhstan
ea0035p584
Combined therapy PRRT with long acting somatostatin analogue: results of 7 years' experience
ea0035p585
The anti-proliferative effect of anti-EGFR tyrosine kinase inhibitor in combination with mitotane on H295R adrenocortical cancer cells
ea0035p586
Gonadal tumor incidence in 45,X/46,XY and 46,XY female patients: experience from one clinical center
ea0035p587
Ovarian tumors in endocrinology: about a series of 17 cases
ea0035p588
Asymptomatic advanced neuroendocrine ovarian tumor: case report
ea0035p589
Analysis of factors affecting the repeatability and reproducibility of elastographic measurements of thyroid nodules
ea0035p590
Should unifocal papillary thyroid microcarcinoma be treated as much radically as multifocal one?
ea0035p591
Pancreatic neuroendocrine tumour with a silent long evolution: case report
ea0035p592
IGF1 gene polymorphism and thyroid cancer
ea0035p593
Comparison of elastography and conventional ultrasonography in the diagnostics of thyroid nodules, elastographic features of follicular lesions of undetermined significance
ea0035p594
Preoperative octreotide therapy in acromegaly: associations between effects on glucose homeostasis and biochemical cure
ea0035p595
Pulmonary neuroendocrine tumor presenting with thyroid gland metastasis: a case report
ea0035p596
Everolimus in monotherapy as a therapeutic option in paragangliomas/pheochromocytomas
ea0035p597
Expression of somatostatin and dopamine receptors in neuroendocrine tumors: correlation of immunohistochemical findings with somatostatin receptor scintigraphy visual scores
ea0035p598
Analysis of allelic imbalance frequency in 10q region covering PAPSS2 and PTEN loci in follicular cell-derived thyroid tumours
ea0035p599
Cushing's syndrome caused by ectopic corticotrophin secretion
ea0035p600
Expression of proliferating markers: PCNA and Cdk1 in hyperplastic lesions of the parathyroid glands
ea0035p601
Immunohistochemical assessment of parafibromin in primary hyperparathyroidism
ea0035p602
Apoptotic cell index in non-neoplastic lesions of the parathyroid glands
ea0035p603
Neuroendocrine cancer of the ampulla of Vater: clinical course in seven patients: material of Department of Endocrinology in Szczecin, Poland
ea0035p604
'Noninsulinoma pancreatogenous hypoglycemia syndrome'; a case report of adult nesidioblastosis from Turkey
ea0035p605
Breast metastasis from medullary thyroid carcinoma in a man
ea0035p606
A rapid thymic carcinoma in a patient with multiple endocrine neoplasia type 1
ea0035p607
Metastatic bone disease in patients with neuroendocrine tumors
ea0035p608
Adrenocortical carcinomas: retrospective analysis of the last 22 years
ea0035p609
The value of parathyroid hormone determination in ultrasound-guided fine-needle aspirates (FNA-PTH) for preoperative localization of parathyroid lesions.
ea0035p610
TSH suppressive therapy accelerates progression of sacropenia in post-menopausal women
ea0035p611
Metabolic and cardiovascular complications in patients with adrenal incidentalomas
ea0035p612
Circulating tumor cells in neuroendocrine tumor patients
ea0035p613
Female reproduction
Tissue glucose utilization in the different phenotypes of PCOS women
ea0035p614
Post load glucose and insulin vs fasting levels in prediction of type 2 diabetes in women with PCOS
ea0035p615
Screening for cushing syndrome in women with hirsutism and oligomenorrhea
ea0035p616
Identification of elevated urine kisspeptin in pregnant women: a novel non-invasive biomarker of placental function?
ea0035p617
Changes in body composition following 12 months randomized treatment with metformin vs oral contraceptives vs combined treatment in polycystic ovary syndrome
ea0035p618
Serum cocaine and amphetamine-regulated transcript concentrations in women with polycystic ovary syndrome
ea0035p619
Plasma levels of nesfatin-1 in patients with polycystic ovary syndrome
ea0035p620
Pregnancy in women with polycystic ovary syndrome is associated with higher risk of gestational diabetes mellitus, but not of other adverse obstetric outcomes
ea0035p621
Study on pregnancy outcomes in patients with type 1 diabetes mellitus having self-control skills
ea0035p622
Liver enzymes in normal-weight women with polycystic ovary syndrome
ea0035p623
Prevalence of metabolic syndrome in obese women with polycystic ovary syndrome
ea0035p624
Prevalence of dysglycaemia in obese women with polycystic ovary syndrome
ea0035p625
Simultaneous determination of salivary androgens by liquid chromatography-tandem mass spectrometry: analytical and biological validation
ea0035p626
Mosaic Turner syndrome and pituitary microadenoma in patient with polyglandular autoimmune syndrome type II
ea0035p627
New endocrine and intracellular regulators of reproductive functions
ea0035p628
Birth weight is associated with important clinical and biochemical parameters of PCOS
ea0035p629
Expression of P450arom mRNA in the ovary and brain of Indian teleosts, Labeo rohita and Anabas testudineus: seasonal variation and effects of gonadotropin
ea0035p630
The relationship between clinico-biochemical features in women with polycystic ovary syndrome and fertility treatment outcomes
ea0035p631
Primary amenorrhea due to gonadal disgenesis: chromosome 13 abnormality not detected previously: a case report
ea0035p632
Increased occurrence of proinflammatory IL17, IL6 and MCP-1 cytokines and resistin with the overweight-associated polycystic ovarian syndrome, pituitary adenome and obesity
ea0035p633
Mice lacking anti-Mullerian hormone signaling are protected against the age-related decline in metabolism
ea0035p634
Thyroid disorders in young females with polycystic ovary syndrome: is thyroid volume associated with serum IGF1 level?
ea0035p635
The prevalence of autoimmune thyroiditis and hypothyroidism in PCOS women
ea0035p636
Systolic blood pressure and fatty acid-binding protein 4 predict pregnancy-induced hypertension in overweight nulliparous women
ea0035p637
Wolfram syndrome with hypergonadotropic hypogonadism: case report
ea0035p638
rhAMH inhibits CYP19 and P450scc mRNA expression in granulosa-lutein cells treated with gonadotropin
ea0035p639
The obesity effects on features of polycystic ovary syndrome
ea0035p640
Relationship between visceral adiposity index, menstrual disorders and hormonal, biochemical and ultrasound parameters in women with polycystic ovary syndrome
ea0035p641
Elevated environmental testosterone equivalent concentration in women with polycystic ovary syndrome
ea0035p642
The FSHR polymorphism p.N680S mediates different response kinetics to FSH in vitro
ea0035p643
The PCOS evolutionary paradox: a GWAS-based, in silico, evolutionary explanation
ea0035p644
How to estimate insulin resistance in PCOS patients: HOMA-IR or QUICKI?
ea0035p645
BMP15 gene dosage as a relevant X-linked determinant of ovarian development and function
ea0035p646
A sensitive method for estrogen profiling in human serum by liquid chromatography-tandem mass spectrometry
ea0035p647
Metabolic fingerprint of serum in first trimester of healthy pregnancy permits the prediction of macrosomia
ea0035p648
Mineral balance, parathormone and vitamin D in patients with policystic ovary syndrome
ea0035p649
Relevance of estrogen activating STS and inactivating SULT1E1 enzymes and estrogen receptors [alpha/beta] in patients with advanced ovarian cancer
ea0035p650
Copeptin in polycystic ovary syndrome
ea0035p651
Inverse relationship between hSHBG affinity for testosterone and hSHBG concentration revealed by surface plasmon resonance
ea0035p652
Evaluation of hormonal pattern and index of oxidative stress in normal weight women with polycystic ovary syndrome
ea0035p653
Ovarian steroid cell tumor not otherwise specified with virilizing manifestations: clinical case
ea0035p654
Dietetic Therapy aimed to restart menstrual period in patients affected by anorexia nervosa in weight recovery
ea0035p655
Valuation of fat tissue distribution in young women with polycystic ovarian syndrome
ea0035p656
Serum leptin concentration in gestational diabetes
ea0035p657
High resolution mass spectrometry to study hormonal regulation of cervical mucus proteome during the menstrual cycle
ea0035p658
ThyrART: a prospective study on thyroid function and autoimmunity during ovarian stimulation for IVF
ea0035p659
Spontaneous fertility and pregnancy outcome in 321 women with Turner syndrome
ea0035p660
Mood disturbances in women with polycystic ovary syndrome
ea0035p661
Demographic characteristics and therapeutical management in patients with primary ovarian insufficiency
ea0035p662
Plasma adhesion molecules concentrations in women with type 1 diabetes mellitus and polycystic ovary syndrome
ea0035p663
The relationship between serum lipocalin-2 levels and insulin resistance in patients with PCOS
ea0035p664
Characterization of the signaling and ovarian functions of bone morphogenetic protein 8
ea0035p665
Does polycystic ovary syndrome influence incidence nonalcoholic fatty liver disease in women?
ea0035p666
Increased prolactin levels cause increased MPV in women with PCOS
ea0035p667
Growth hormone IGF axis basic
Effects of partial deficiency of IGF1 on hepatocellular architecture
ea0035p668
Mechanism of hepatoprotection derived from IGF1 replacement therapy
ea0035p669
Young female with acromegaloid features, pituitary macroadenoma, and an uncomplicated pregnancy
ea0035p670
Epigenetic regulation of GH target genes and its relation to in vivo GH signaling in skeletal muscle of adult human males: a pilot study
ea0035p671
Demographic and clinical characteristics and treatment patterns of polish acromegalic patients switched to lanreotide AUTOGEL 120
ea0035p672
Incidence and late prognosis of acromegaly in Denmark: preliminary data
ea0035p673
Pollution agents contribution in goitrogenous process in dobrogea: the Southeastern boundary of Romania
ea0035p674
The etiologies of growth hormone insufficiences: about 170 cases
ea0035p675
GH replacement therapy affects the morphology and function of the left ventricle in patients with adult-onset GH deficiency
ea0035p676
Positive impact of GH treatment on trabecular bone using grey-level texture analysis
ea0035p677
Analysis of bioactive IGF-binding proteins by quantitative western ligand blotting in different biological fluids for biomarker research
ea0035p678
Latest results from the PATRO Adults study of Omnitrope(R) for the treatment of adult patients with GH deficiency
ea0035p679
Increased relative amount of visceral and subcutaneous adipose tissue in long-lived GH-releasing hormone knockout (GHRHKO) mice; is it beneficial or not?
ea0035p680
Effects of two mTOR inhibitors on in-vitro models of GH-secreting pituitary adenomas
ea0035p681
Evaluation of the effect of X chromosome abnormalities on the response to GH therapy in children with turner syndrome
ea0035p682
The pathophysiology of increased hepatic IGF1 expression in an ovine model of polycystic ovary syndrome
ea0035p683
Male reproduction
The effects of improving testosterone levels on cardiovascular risk markers in young men with idiopathic hypogonadotropic hypogonadism: preliminary findings from a prospective study
ea0035p684
An analysis of the possible relationship circulating concentrations of ghrelin, LH, FSH, testosterone and inhibin B at the time of puberty in normal healthy boys
ea0035p685
Semen quality in patients with newly diagnosed non-Hodgkin lymphoma
ea0035p686
Hypogonadism in aged hospitalized male patients: prevalence and clinical outcome
ea0035p687
Is elevated red blood cell distribution width a new risk factor for polycystic ovary syndrome?
ea0035p688
Analysing by decade, testosterone undecanoat depot injectable does not increases prostate volume: study during up to 6 years on hypogonadic patients
ea0035p689
The variant FSHB -211G>T attenuates serum FSH levels in the supraphysiological gonadotropin setting of Klinefelter syndrome
ea0035p690
Clinical correlates of enlarged prostate size in subjects with sexual dysfunction
ea0035p691
Clinical implications of measuring prolactin levels in males of infertile couples
ea0035p692
Seminal, ultrasound and psychobiological parameters correlate with metabolic syndrome in male members of infertile couples
ea0035p693
Seminal, clinical and color-Doppler ultrasound correlations of prostatitis-like symptoms in males of infertile couples
ea0035p694
Sexual functioning in patients with end-stage liver disease before and after liver transplantation
ea0035p695
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit
ea0035p696
Metformin in vitro and in vivo increases adenosine signalling in rabbit corpora cavernosa
ea0035p697
Waist circumference and waist-to-height ratio in relation to semen quality and serum reproductive hormones levels among Estonian fertile men
ea0035p698
A possible association between circulating concentrations of obestatin, LH, FSH, testosterone and inhibin B during puberty in normal healthy boys
ea0035p699
46 XX male syndrome with hypogonadotrophic hypogonadism: a case report
ea0035p700
Gonadal and sexual function in young/middle aged human immunodeficiency virus (HIV)-infected men
ea0035p701
Effect of 17[beta]-estradiol on germ cell apoptosis by modulating the expression of SCF/c-kit, FasL/FasR and regucalcin
ea0035p702
Evaluation of adipocytokine levels and vascular reactivity in hypogonadotropic hypogonadal males
ea0035p703
Current smoking is associated with lower ejaculate and seminal vesicles volume but higher testosterone levels compared to no-smoking in males of infertile couples
ea0035p704
Relationship among nutritional patterns, metabolic parameters and reproductive hormones In healthy young men
ea0035p705
Relationship of testis size and LH levels with incidence of major adverse cardiovascular events in older men with sexual dysfunction
ea0035p706
Lack of sexual privacy affects psychological and marital domains of male sexual dysfunction
ea0035p707
Regulation of pro-inflammatory cytokines (TNF-[alpha] and IL-6) secretion by LPS in immature rat peritubular cells
ea0035p708
Neuroendocrinology
Identification of the kisspeptin cells of the arcuate nucleus as 'pulse generators' for gonadotropin releasing hormone.
ea0035p709
Meal-induced plasma ghrelin suppression in different phases of anorexia nervosa
ea0035p710
Acromegaly and pregnancy: A descriptive case series
ea0035p711
Papillary thyroid carcinoma associated with silent paraganglioma: An atypical MEN syndrome?
ea0035p712
Copeptin for the differential diagnosis and therapy management of hyponatremia in hospitalized patients - 'The Co-MED-Study'
ea0035p713
Clinical symptoms and characteristics of hospitalized patients with severe hyponatremia
ea0035p714
Clinical manifestations of neurofibromatosis type 1
ea0035p715
Long-term remission and recurrence rates after transsphenoidal surgery for cushing's disease
ea0035p716
A rare incident of gastric mucinous adenocarcinoma in an acromegalic patient
ea0035p717
Bilateral ovariectomy and neurodegeneration
ea0035p718
Effects of pharmacological blockade of glucocorticoids on energy homeostasis control by liver and pancreas in rats without pineal gland
ea0035p719
Copeptin levels measured after pituitary surgery predict later development of diabetes insipidus
ea0035p720
Multiple endocrine neoplasia presenting with a novel mutation on menin gene
ea0035p721
Long-term remission and recurrence rate in a cohort of Cushing's disease: The need for long-term follow-up
ea0035p722
Cinacalcet hydrochloride more efficiently controls serum calcium levels in mild-asymptomatic primary hyperparathyroidism without surgery criteria, as compared with surgical cases
ea0035p723
Treatment of SIADH in a patient with fatal familial insomnia (FFI) and hypersomnia
ea0035p724
If there are differences in postoperative pituitary dysfunction in patients with micro and macroadenomas.
ea0035p725
Radiotherapy or surgical treatment, may affect response of cabergoline in the giant prolactinomas? Report of two cases
ea0035p726
Hyperprolactinemia in women and men
ea0035p727
Changes of metabolic status in children with acquired and congenital multiple pituitary insufficiency
ea0035p728